NICE rejects NHS funding for Portola's Ondexxya
admin 24th April 2020 Uncategorised 0NICE says there is “no direct evidence” that the drug is better than existing treatment
More: NICE rejects NHS funding for Portola's Ondexxya
Source: News
NICE says there is “no direct evidence” that the drug is better than existing treatment
More: NICE rejects NHS funding for Portola's Ondexxya
Source: News
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' drug pricing rule
Fierce Pharma Politics—Judge blocks Trump's 'most favored nation' d
Feds consider half-doses of Moderna COVID-19 vaccine to stretch supplies, as U.K. spaces out Pfizer, AstraZeneca shots
Feds consider half-doses of Moderna COVID-19 vaccine to stretch suppl
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 wit
© 1994 - 2021 B.M. Pharmaceuticals